Surgery Partners (SGRY) Reiterated at Overweight by Cantor Fitzgerald Amid Weaker Q1 Data

April 7, 2026 7:27 AM

Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $25.00 price target on Surgery Partners (NASDAQ: SGRY).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found